In clinical trials, digestive issues such as nausea, diarrhea, vomiting, and constipation were reported more frequently in people taking semaglutide than in those taking a placebo.[6] Most of these symptoms are mild to moderate and tend to improve as the body adjusts to the medication
However, as a weight-loss drug, it is not usually covered by insurance plans and Medicare
Each unit of this product is tested under strict quality control systems to meet global standards
The link between IGF-1 and cancer is complex
Who is a good candidate for using GLP-1 medications for weight loss
Once there, they may encourage the growth of new brain cells, adjust chemical signals between neurons, or help guard existing cells from harm